CordenPharma

Formed as the global pharmaceutical service & manufacturing platform of International Chemical Investors Group in 2006, CordenPharma is your full-service partner in the Contract Development & Manufacturing (CDMO) of APIs, Excipients, Drug Products, and associated Packaging Services. Through a growing network of cGMP facilities across Europe and the US organized under five Technology Platforms – Peptides - Lipids & Carbohydrates - Highly Potent & Oncology - Injectables - Small Molecules – CordenPharma experts translate complex processes, ideas and projects at any stage of development into high-value products.

• >> Full-Service CDMO Organized under 5 Technology Platforms
• >> 11 cGMP Manufacturing Facilities in Europe / US and 1 R&D Research Laboratory
• >> 2600 Employees.

CordenPharma Mission

CordenPharma is a full-service partner in the cGMP Contract Development & Manufacturing of Active Pharmaceutical Ingredients (APIs), Excipients, Drug Products and Pharma Packaging Services, supporting leading pharmaceutical & biotechnology companies to achieve product success for their patients’ healthier lives.

OUR VISION

CordenPharma’s vision is to be a trusted, reliable and highly respected CDMO to Pharmaceutical & Biotechnology companies by providing industry-leading Integrated Product Solutions with integrity, transparency & flexibility on all levels of the organization.

OUR MISSION

We strive for excellence in supporting global Pharmaceutical & Biotechnology customers with high quality products for the well-being of patients.

OUR FOUNDATION - KEY PILLARS

• Customer Centricity& Service
• Operational Excellence
• CollaborativePartnerships
• People & Culture